Benefits of jejunostomy feeding in patients who underwent gastrectomy for cancer treatment.

BACKGROUND

Gastric cancer is associated with significant undernutrition responsible for an increase in morbidity and mortality after gastrectomy.

AIM

To evaluate the impact of enteral nutrition by jejunostomy feeding in patients undergoing gastrectomy for cancer.

METHODS

Between 2003 and 2017, all patients undergoing gastrectomy for cancer treatment were included retrospectively. A group with jejunostomy (J + group) and a group without jejunostomy (J - group) were compared.

RESULTS

Of the 172 patients included, 60 received jejunostomy. Preoperatively, the two groups were comparable with respect to the nutritional parameters studied (body mass index, albumin, ). In the postoperative period, the J + group lost less weight and albumin: 5.74 ± 8.4 9.86 ± 7.5 kg ( = 0.07) and 7.2 ± 5.6 14.7 ± 12.7 g/L ( = 0.16), respectively. Overall morbidity was 25% in the J + group and 36.6% in the J - group ( = 0.12). The J + group had fewer respiratory, infectious, and grade 3 complications: 0% 5.4% ( = 0.09), 1.2% 9.3% ( = 0.03), and 0% 4.7% ( = 0.05), respectively. The 30-day mortality was 6.7% in the J + group and 6.3% in the J - group ( = 0.91).

CONCLUSION

Jejunostomy feeding after gastrectomy improves nutritional characteristics and decreases postoperative morbidity. A prospective study could confirm our results.